Repligen (RGEN) Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $169.04 +1.32%
Financial Fact:
(Loss) income from operations: 3.75M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
(Loss) income from operations: 3.75M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.24, $0.09 better than the analyst estimate of $0.15. Revenue for the quarter came in at $32.5 million versus the consensus estimate of $31.48 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Is Treasury selloff a major issue for stock market bulls?
- Tesla to launch Cybercab in Austin this month - report
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
